circCIMT Silencing Promotes Cadmium‐Induced Malignant Transformation of Lung Epithelial Cells Through the DNA Base Excision Repair Pathway
Source abstract
Abstract
Abstract Changes in gene expression in lung epithelial cells are detected in cancer tissues during exposure to pollutants, highlighting the importance of gene‐environmental interactions in disease. Here, a Cd‐induced malignant transformation model in mouse lungs and bronchial epithelial cell lines is constructed, and differences in the expression of non‐coding circRNAs are analyzed. The migratory and invasive abilities of Cd‐transformed cells are suppressed by circCIMT. A significant DNA damage response is observed after exposure to Cd, which increased further following circCIMT‐interference. It is found that APEX1 is significantly down‐regulated following Cd exposure. Furthermore, it is demonstrated that circCIMT bound to APEX1 during Cd exposure to mediate the DNA base excision repair (BER) pathway, thereby reducing DNA damage. In addition, simultaneous knockdown of both circCIMT and APEX1 promotes the expression of cancer‐related genes and malignant transformation after long‐term Cd exposure. Overall, these findings emphasis the importance of genetic‐epigenetic interactions in chemical‐induced cancer transformation.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Circular RNAs in diseases · MicroRNA in disease regulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Respiratory Disease The First Affiliated Hospital of Guangzhou Medical University Guangzhou 510120 P. R. China
Institute for Chemical Carcinogenesis Guangzhou Medical University Guangzhou 511436 P. R. China
School of Public Health Baotou Medical College Baotou 014030 P. R. China
Funding
National Natural Science Foundation of China
References (46)
Show source-provided references
1. 10.1016/j.mrfmmm.2003.07.01110.1016/j.mrfmmm.2003.07.011 ↗
2. 10.1007/s11356-019-06840-110.1007/s11356-019-06840-1 ↗
3. 10.1166/jnn.2020.1874810.1166/jnn.2020.18748 ↗
4. 10.1038/s41576-019-0158-710.1038/s41576-019-0158-7 ↗
5. 10.1016/j.trecan.2020.01.01210.1016/j.trecan.2020.01.012 ↗
6. 10.1016/j.canlet.2020.08.01310.1016/j.canlet.2020.08.013 ↗
7. 10.1038/onc.2017.36110.1038/onc.2017.361 ↗
8. Qu D. · Am. J. Cancer Res. · 2018 · 8 · 1387
9. 10.1158/1078-0432.CCR-18-144710.1158/1078-0432.CCR-18-1447 ↗
10. 10.1158/0008-5472.CAN-14-324710.1158/0008-5472.CAN-14-3247 ↗
11. 10.1038/nrc.2015.410.1038/nrc.2015.4 ↗
12. 10.1007/978-3-7643-8340-4_610.1007/978-3-7643-8340-4_6 ↗
13. 10.1146/annurev-biochem-013118-11131510.1146/annurev-biochem-013118-111315 ↗
14. 10.1016/j.dnarep.2020.10292110.1016/j.dnarep.2020.102921 ↗
15. 10.1002/em.2208710.1002/em.22087 ↗
16. 10.1016/j.molcel.2021.05.00910.1016/j.molcel.2021.05.009 ↗
17. 10.1016/j.archoralbio.2020.10498710.1016/j.archoralbio.2020.104987 ↗
18. 10.3390/cells1003062110.3390/cells10030621 ↗
19. 10.1016/j.semcancer.2017.03.00310.1016/j.semcancer.2017.03.003 ↗
20. 10.1016/j.taap.2018.01.02210.1016/j.taap.2018.01.022 ↗
21. 10.1016/j.cell.2017.01.00210.1016/j.cell.2017.01.002 ↗
22. 10.1080/07357907.2020.172152310.1080/07357907.2020.1721523 ↗
23. 10.7150/ijbs.6462810.7150/ijbs.64628 ↗
24. 10.1002/jcla.2325210.1002/jcla.23252 ↗
25. 10.1186/s12943-020-01253-y10.1186/s12943-020-01253-y ↗
26. 10.3390/cancers1321535210.3390/cancers13215352 ↗
27. 10.1038/s41580-020-0243-y10.1038/s41580-020-0243-y ↗
28. 10.1002/advs.20200337610.1002/advs.202003376 ↗
29. 10.1126/scisignal.aba809110.1126/scisignal.aba8091 ↗
30. 10.1111/nan.1258410.1111/nan.12584 ↗
31. 10.1007/s00439-019-02004-w10.1007/s00439-019-02004-w ↗
32. 10.1038/s41590-020-0802-610.1038/s41590-020-0802-6 ↗
33. 10.3346/jkms.2021.36.e18310.3346/jkms.2021.36.e183 ↗
34. 10.1093/eurheartj/ehx501.P44010.1093/eurheartj/ehx501.P440 ↗
35. 10.1093/nar/gkaa124610.1093/nar/gkaa1246 ↗
36. 10.1016/j.apsb.2020.10.02210.1016/j.apsb.2020.10.022 ↗
37. 10.1093/nar/gkab114610.1093/nar/gkab1146 ↗
38. 10.1038/s41467-022-29369-310.1038/s41467-022-29369-3 ↗
39. 10.1016/j.scitotenv.2021.15107810.1016/j.scitotenv.2021.151078 ↗
40. 10.1038/s41588-019-0574-910.1038/s41588-019-0574-9 ↗
41. 10.1158/2159-8290.CD-20-072510.1158/2159-8290.CD-20-0725 ↗
42. 10.1016/j.chom.2021.04.00610.1016/j.chom.2021.04.006 ↗
43. 10.1021/acs.est.8b0691610.1021/acs.est.8b06916 ↗
44. 10.1016/j.envint.2020.10575510.1016/j.envint.2020.105755 ↗
45. 10.1002/advs.20180065410.1002/advs.201800654 ↗
46. 10.1007/s00204-021-03138-510.1007/s00204-021-03138-5 ↗